Home › Companies › GeneDx Holdings Corp. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and GeneDx Holdings Corp.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 18, 2026: 3 items on GeneDx Holdings Corp.’s Form 8-K, filed June 23, 2026: 3 passed (calculated).
Significant dissent: 1 director (24.3% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Corvex (13D, 17.9%, as of May 22, 2026)
Explore GeneDx Holdings Corp. in the interactive database Compare manager voting policies
These tallies are GeneDx Holdings Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Katherine Stueland | 18,325,894 | -- | -- | 5,893,466 | 3,409,327 | 76% | Passed (calculated) | — |
| 2. The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 27,466,639 | 158,884 | 3,164 | -- | -- | 99.4% | Passed (calculated) | — |
| 3. Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement | 22,705,946 | 1,471,593 | 41,821 | -- | -- | 94% | Passed (calculated) | — |
Source: GeneDx Holdings Corp., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
328 asset managers disclosed a vote on at least one GeneDx Holdings Corp. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of GeneDx Holdings Corp.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 6 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of Director: Katherine Stueland
GeneDx Holdings Corp.’s own tally for this item (“Elect Director: Katherine Stueland”): 18,325,894 for, 5,893,466 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 102 asset managers below reported 6,293,672 for, 2,149,103 withheld, 401,788 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 1,227,663 | 0 | 0 | 0 | For |
| Vanguard | 1,023,988 | 0 | 13 | 0 | For |
| Fidelity | 632,814 | 0 | 0 | 75,525 | Mixed |
| BlackRock | 502,409 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 0 | 478,123 | Withhold |
| Invesco | 459,948 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 352,688 | Withhold |
| Capital Group | 335,461 | 0 | 0 | 0 | For |
| BNY Mellon | 292,059 | 0 | 0 | 721 | For |
| OBERWEIS FUNDS | 0 | 0 | 0 | 247,300 | Withhold |
| Putnam | 229,024 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 0 | 222,243 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 201,666 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 179,847 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 0 | 0 | 173,405 | Withhold |
| Charles Schwab | 172,322 | 0 | 0 | 0 | For |
| Royce | 162,425 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 156,662 | Withhold |
| ALGER FUNDS | 0 | 0 | 0 | 144,840 | Withhold |
| Hartford | 139,816 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 0 | 104,675 | Withhold |
| Aberdeen | 92,816 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 87,558 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 65,067 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 63,520 | Withhold |
Showing the 25 largest of 102 asset managers. All 102 are in the interactive database (link above).
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% of fund votes cast · no official result
The 2 asset managers below reported this as one line covering every nominee; it is not attributed to any one director, and no share total is shown for it.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 10,701 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 1 | 0 | 0 | 0 | For |
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Approval, on a non-binding advisory basis, the compensation of our named executive officers.
GeneDx Holdings Corp.’s own tally for this item (“3. The Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive”): 22,705,946 for, 1,471,593 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 1,227,663 | 0 | 0 | 0 | For |
| Vanguard | 1,023,998 | 3 | 0 | 0 | For |
| Fidelity | 708,339 | 0 | 0 | 0 | For |
| BlackRock | 502,409 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 478,123 | 0 | 0 | 0 | For |
| Invesco | 459,948 | 0 | 0 | 0 | For |
| MFS | 352,688 | 0 | 0 | 0 | For |
| Capital Group | 0 | 335,461 | 0 | 0 | Against |
| BNY Mellon | 721 | 292,059 | 0 | 0 | Against |
| OBERWEIS FUNDS | 247,300 | 0 | 0 | 0 | For |
| Putnam | 229,024 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 222,243 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 201,666 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 179,847 | 0 | 0 | Against |
| Waddell & Reed | 173,405 | 0 | 0 | 0 | For |
| Charles Schwab | 172,322 | 0 | 0 | 0 | For |
| Royce | 162,425 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 156,662 | 0 | 0 | 0 | For |
| ALGER FUNDS | 144,840 | 0 | 0 | 0 | For |
| Hartford | 139,816 | 0 | 0 | 0 | For |
| Thrivent | 104,675 | 0 | 0 | 0 | For |
| Aberdeen | 92,816 | 0 | 0 | 0 | For |
| Dimensional | 87,558 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 65,067 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 63,520 | 0 | 0 | 0 | For |
Fund voting reports, all 104 managers: 8,033,029 for, 821,521 against, 914 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Casdin Capital, LLC | 3,007,164 | 0 | 0 | 0 | For |
| Corvex Management LP | 2,912,570 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 964,704 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 656,792 | 0 | 0 | 0 | For |
| BlackRock | 644,749 | 0 | 0 | 0 | For |
| Amova Asset Management Co., Ltd. | 629,640 | 0 | 0 | 0 | For |
| Invesco | 507,951 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 507,267 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 478,196 | 0 | 0 | Against |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 365,004 | 0 | 0 | 0 | For |
| Putnam | 355,367 | 0 | 0 | 0 | For |
| Wellington | 298,971 | 0 | 0 | 0 | For |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 294,167 | 0 | 0 | 0 | For |
| State Street | 293,982 | 0 | 0 | 0 | For |
| Citadel | 293,141 | 0 | 0 | 0 | For |
| Aberdeen | 278,542 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 277,598 | 0 | 0 | 0 | For |
| OBERWEIS ASSET MANAGEMENT INC/ | 257,300 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 255,008 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 245,007 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 226,968 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 226,116 | 0 | 0 | 0 | For |
| Capital Group | 0 | 218,730 | 0 | 0 | Against |
| FRED ALGER MANAGEMENT, LLC | 206,347 | 0 | 0 | 0 | For |
| Fidelity | 195,159 | 0 | 0 | 0 | For |
Institutional-manager reports, all 253 managers: 16,761,690 for, 1,066,880 against, 824 abstained, 113 not voted, 7,955 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| MFS | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| BNY Mellon | 0 | 0 | 0 | 0 | -- |
| OBERWEIS FUNDS | 0 | 0 | 0 | 0 | -- |
| Putnam | 0 | 0 | 0 | 0 | -- |
| HARBOR FUNDS | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Waddell & Reed | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Royce | 0 | 0 | 0 | 0 | -- |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 0 | -- |
| ALGER FUNDS | 0 | 0 | 0 | 0 | -- |
| Hartford | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 103 managers: 14,954 for, 914 abstained, 8,731,855 1 year, 96,991 3 year, 49 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Casdin Capital, LLC | 0 | 0 | 0 | 0 | -- |
| Corvex Management LP | 0 | 0 | 0 | 0 | -- |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 0 | 0 | 0 | 0 | -- |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Amova Asset Management Co., Ltd. | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Newton Investment Management North America, LLC | 0 | 0 | 0 | 0 | -- |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 0 | 0 | 0 | -- |
| Putnam | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| OBERWEIS ASSET MANAGEMENT INC/ | 0 | 0 | 0 | 0 | -- |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| First Light Asset Management, LLC | 226,116 | 0 | 0 | 0 | For |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| FRED ALGER MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 241 managers: 237,967 for, 239 abstained, 113 not voted, 17,469,202 1 year, 76,611 3 year. Showing the 25 largest; every one is in the interactive database (link above).
— Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 1 managers: 10,701 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 0 | 0 | 0 | -- |
| Williamson Legacy Group, LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 2 managers: 800 1 year, 1 3 year.
— of fund votes cast · no official result
The 3 asset managers below reported 44,779 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Granahan Investment Management, LLC | 0 | 0 | 0 | 0 | -- |
| APG Asset Management US Inc. | 0 | 0 | 0 | 0 | -- |
| CIDEL ASSET MANAGEMENT INC | 0 | 0 | 0 | 0 | -- |
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Prior year: 99.8% for (June 18, 2025 meeting) ▼ 0.4 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
GeneDx Holdings Corp.’s own tally for this item (“2. The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 27,466,639 for, 158,884 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 104 asset managers below reported 8,841,981 for, 12,370 against, 914 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 1,227,663 | 0 | 0 | 0 | For |
| Vanguard | 1,024,001 | 0 | 0 | 0 | For |
| Fidelity | 708,339 | 0 | 0 | 0 | For |
| BlackRock | 502,409 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 478,123 | 0 | 0 | 0 | For |
| Invesco | 459,948 | 0 | 0 | 0 | For |
| MFS | 352,688 | 0 | 0 | 0 | For |
| Capital Group | 335,461 | 0 | 0 | 0 | For |
| BNY Mellon | 292,780 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 247,300 | 0 | 0 | 0 | For |
| Putnam | 229,024 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 222,243 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 201,666 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 179,847 | 0 | 0 | 0 | For |
| Waddell & Reed | 173,405 | 0 | 0 | 0 | For |
| Charles Schwab | 172,322 | 0 | 0 | 0 | For |
| Royce | 162,425 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 156,662 | 0 | 0 | 0 | For |
| ALGER FUNDS | 144,840 | 0 | 0 | 0 | For |
| Hartford | 139,816 | 0 | 0 | 0 | For |
| Thrivent | 104,675 | 0 | 0 | 0 | For |
| Aberdeen | 92,816 | 0 | 0 | 0 | For |
| Dimensional | 87,558 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 65,067 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 63,520 | 0 | 0 | 0 | For |
Showing the 25 largest of 104 asset managers. All 104 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 29,666,318 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 4.14% |
| 2 | Vanguard | 3.45% |
| 3 | Fidelity | 2.39% |
| 4 | BlackRock | 1.69% |
| 5 | MUTUAL FUND SERIES TRUST | 1.61% |
| 6 | Invesco | 1.55% |
| 7 | MFS | 1.19% |
| 8 | Capital Group | 1.13% |
| 9 | BNY Mellon | 0.99% |
| 10 | OBERWEIS FUNDS | 0.83% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Casdin Capital, LLC | 10.14% |
| 2 | Corvex Management LP | 9.82% |
| 3 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.25% |
| 4 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.21% |
| 5 | BlackRock | 2.17% |
| 6 | Amova Asset Management Co., Ltd. | 2.12% |
| 7 | Invesco | 1.71% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.71% |
| 9 | Newton Investment Management North America, LLC | 1.61% |
| 10 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.23% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Keith A. Meister | 5,356,767 | 18.06% | Schedule 13D, filed May 22, 2026 |
| Meister, Keith A. | 5,356,767 | 18.06% | Schedule 13D, filed May 15, 2026 |
| BlackRock | 1,550,708 | 5.23% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,334,980 | 4.50% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 1,189,069 | 4.01% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 768,001 | 2.59% | Form 13F, quarter ended March 31, 2026 |
| Franklin Templeton | 607,221 | 2.05% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 549,147 | 1.85% | Form 13F, quarter ended March 31, 2026 |
| Invesco | 540,229 | 1.82% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 506,091 | 1.71% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 29,666,318 shares outstanding, as reported by GeneDx Holdings Corp. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At GeneDx Holdings Corp.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 328 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,786 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, the compensation of our named executive officers. — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GeneDx Holdings Corp.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GeneDx Holdings Corp.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
GeneDx Holdings Corp. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “GeneDx Holdings (WGS) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/genedx-holdings-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.